REQUEST A DEMO
Total
USD $0.00
Search more companies

Sociedad Inversiones Farmedicall S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Sociedad Inversiones Farmedicall S.A.S. Profile Updated: January 06, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Sociedad Inversiones Farmedicall S.A.S. is a Colombian company operating in the healthcare and pharmaceutical services sector. The company manages investments and commercial activities related to pharmaceutical distribution, medical services and healthcare related operations. Its activities support healthcare providers and institutional clients within Colombia. Key assets include commercial agreements, healthcare related assets and operational management capabilities. The strategic focus is on supporting healthcare service delivery, operational efficiency and growth within regulated healthcare markets.

Headquarters
Calle 19 # 6-31 Oficina 4603 Centro Comercial Bacata
Bogota D.C.; Bogota D.C; Postal Code: 0110

Contact Details: Purchase the Sociedad Inversiones Farmedicall S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Sociedad Inversiones Farmedicall S.A.S. report to view the information.
Financial Auditors:
Purchase the Sociedad Inversiones Farmedicall S.A.S. report to view the information.
Incorporation Date:
May 27, 2014
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Sociedad Inversiones Farmedicall S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
10%
Total operating revenue
10%
Operating Profit/Loss (EBIT)
228.78%
Total Assets
22.88%
Total Equity
62.04%
Operating Profit Margin (ROS)
6.4%
Quick Ratio
-32.52%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?